Therapy

Thiacetazone - Necessary Evil or Unjustifiable Killer?

Published in TB and Outbreaks Week, May 13th, 1996

Its use results in life-threatening skin reactions in up to one-third of HIV infected tuberculosis patients who are treated with it, but controversy persists regarding the use of thiacetazone in underdeveloped regions.

Is thiacetazone a necessary evil or an unethical alternative to more costly antituberculosis therapies' That thorny question continues to be debated by tuberculosis experts treating patients in poor, developing regions such as Kenya.

Researchers J. van Grokom and D.K. Kibuga of Nairobi, Kenya's National Leprosy Tuberculosis Program suggest that while greater education regarding the potentially life-threatening toxicity of thiacetazone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1996-05-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry